Published on in Vol 10 (2024)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/59167, first published
.

Journals
- Silva P, Rogers S, Hassan-Toufique Z, Tao J, Bruce S, Shireman P, Ramos K. Idealized Framework for Assisting Pharmacovigilance Reporting in an Ambulatory Primary Care and Chronic Disease Management Clinic. Pharmacoepidemiology 2025;4(4):26 View
- Shahrezaei A, Taherkhani S, Dashti L, Garmaroodi G, Nasirinezhad F. Herbal medicine meets machine learning: a systematic review of AI-powered innovation in chronic inflammation management. Discover Applied Sciences 2025;8(2) View
- Phillips B. Towards evidence-based medicine for paediatricians. Archives of Disease in Childhood 2026;111(2):193.2 View
- Ried P, Seifert R. Social media data and its potential for pharmacovigilance: a comparative analysis of reported prevalences regarding drug-induced gingival overgrowth (DIGO). Naunyn-Schmiedeberg's Archives of Pharmacology 2026 View
- Guellil I, Berrachedi Y, Chenni N, Abboud M, Wu J, Wu H, Alex B. Detecting Adverse Drug Events in Social Media: A Brief Literature Review. SN Computer Science 2026;7(2) View
- Nagem Lopes L, Ramos-Silva A, Gallo de Castro A, Corrêa de Matos G. Potential utility of social media in pharmacovigilance to identify adverse events and safety signals: a scoping review. Research in Social and Administrative Pharmacy 2026;22(5):617 View
Books/Policy Documents
- Chinzowu T, Nishtala P. Reference Module in Biomedical Sciences. View
